Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis.

Tekijä Gilles Riveau, Dominique Deplanque, Franck Remoué, Anne-Marie Schacht, Hubert Vodougnon, Monique Capron, Michel Thiry, Joseph Martial, Christian Libersa, André Capron
Julkaistu 2012-01-01